Key terms
About DTIL
Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's proprietary genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane on January 26, 2006 and is headquartered in Durham, NC.
Key terms
Smart score
Latest DTIL news
No recent news articles are available for DTIL
No recent press releases are available for DTIL
DTIL Financials
Key terms
DTIL Forecasts
analyst rating
- buy
- hold
- sell